Dimensional Fund Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.4M | Buy |
|
|||||
|
2025
Q1 | $50.9M | Buy |
|
|||||
|
2024
Q4 | $34.5M | Sell |
|
|||||
|
2024
Q3 | $28.2M | Buy |
|
|||||
|
2024
Q2 | $52.3M | Buy |
|
|||||
|
2024
Q1 | $47.6M | Buy |
|
|||||
|
2023
Q4 | $47.6M | Buy |
|
|||||
|
2023
Q3 | $42.8M | Buy |
|
|||||
|
2023
Q2 | $45M | Buy |
|
|||||
|
2023
Q1 | $40.4M | Buy |
|
|||||
|
2022
Q4 | $36.6K | Buy |
|
|||||
|
2022
Q3 | $46.7M | Buy |
|
|||||
|
2022
Q2 | $47.2M | Buy |
|
|||||
|
2022
Q1 | $57.9M | Buy |
|
|||||
|
2021
Q4 | $45.4M | Buy |
|
|||||
|
2021
Q3 | $40M | Sell |
|
|||||
|
2021
Q2 | $47.5M | Buy |
|
|||||
|
2021
Q1 | $43M | Buy |
|
|||||
|
2020
Q4 | $34.4M | Buy |
|
|||||
|
2020
Q3 | $33.5M | Buy |
|
|||||
|
2020
Q2 | $28.6M | Buy |
|
|||||
|
2020
Q1 | $17.7M | Buy |
|
|||||
|
2019
Q4 | $22.9M | Buy |
|
|||||
|
2019
Q3 | $19.1M | Buy |
|
|||||
|
2019
Q2 | $18.5M | Buy |
|
|||||
|
2019
Q1 | $13.4M | Buy |
|
|||||
|
2018
Q4 | $10.4M | Buy |
|
|||||
|
2018
Q3 | $2.96M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $4.16M | Sell |
|
|||||
|
2014
Q4 | $4.44M | Buy |
|
|||||
|
2014
Q3 | $2.71M | Buy |
|
|||||
|
2014
Q2 | $735K | Buy |
|